These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Olanzapine-induced urinary incontinence: treatment with ephedrine. Vernon LT; Fuller MA; Hattab H; Varnes KM J Clin Psychiatry; 2000 Aug; 61(8):601-2. PubMed ID: 10982206 [No Abstract] [Full Text] [Related]
6. Antidepressant augmentation with low-dose olanzapine in obsessive-compulsive disorder. Marusic A; Farmer A Br J Psychiatry; 2000 Dec; 177():567. PubMed ID: 11270368 [No Abstract] [Full Text] [Related]
7. Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat. Oerther S; Ahlenius S J Pharmacol Exp Ther; 2000 Feb; 292(2):731-6. PubMed ID: 10640312 [TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia in patients with schizophrenia who are treated with olanzapine. Lindenmayer JP; Smith RC; Singh A; Parker B; Chou E; Kotsaftis A J Clin Psychopharmacol; 2001 Jun; 21(3):351-3. PubMed ID: 11386505 [No Abstract] [Full Text] [Related]
9. Olanzapine and pancreatitis. Hagger R; Brown C; Hurley P Br J Psychiatry; 2000 Dec; 177():567. PubMed ID: 11102343 [No Abstract] [Full Text] [Related]
10. Olanzapine-induced agranulocytosis: a case report and review of the literature. Tolosa-Vilella C; Ruiz-Ripoll A; Mari-Alfonso B; Naval-Sendra E Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):411-4. PubMed ID: 11817522 [TBL] [Abstract][Full Text] [Related]